APA (7th ed.) Citation

CJ, C., OA, C., SW, M., ST, N., L, G., & B, C. (2024). Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study. Infection and drug resistance, 17, 4427. https://doi.org/10.2147/IDR.S475462

Chicago Style (17th ed.) Citation

CJ, Clancy, Cornely OA, Marcella SW, Nguyen ST, Gozalo L, and Cai B. "Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study." Infection and Drug Resistance 17 (2024): 4427. https://doi.org/10.2147/IDR.S475462.

MLA (9th ed.) Citation

CJ, Clancy, et al. "Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study." Infection and Drug Resistance, vol. 17, 2024, p. 4427, https://doi.org/10.2147/IDR.S475462.